Prognostic impact of cytokines and chemokines in bronchoalveolar lavage fluid on acute exacerbation of fibrosing interstitial lung disease

被引:0
|
作者
Furuta, Katsuyuki [1 ]
Fujimoto, Daichi [1 ]
Matsunashi, Atsushi [2 ]
Shibaki, Ryota [1 ]
Taniya, Shinnosuke [3 ]
Tanaka, Masanori [1 ]
Shimada, Yuri [2 ]
Nagata, Kazuma [2 ]
Tomii, Keisuke [2 ]
Yamamoto, Nobuyuki [1 ]
机构
[1] Wakayama Med Univ, Internal Med 3, 811Kimiidera, Wakayama 6418509, Japan
[2] Kobe City Med Ctr Gen Hosp Kobe, Dept Resp Med, Kobe, Japan
[3] Revorf Co Ltd, Tokyo, Japan
关键词
Interstitial lung disease; Lung fibrosis; cytokine; Biomarker; Retrospective study; IDIOPATHIC PULMONARY-FIBROSIS; GM-CSF; INFLAMMATION; IL-8;
D O I
10.1016/j.rmed.2024.107721
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: Acute exacerbation of fibrosing interstitial lung disease (AE-FILD) is a serious condition with a high mortality rate. We aimed to comprehensively analyze cytokines in bronchoalveolar lavage fluid and their association with the clinical course of AE-FILD. Methods: We retrospectively enrolled 60 patients with AE-FILD who underwent bronchoalveolar lavage. We comprehensively measured 44 cytokines and chemokines in the obtained bronchoalveolar lavage fluid using a Luminex analyzer. Patients were grouped into those who died within 90 days (non-survival group) and survived beyond 90 days (survival group) to investigate the association of the levels of cytokines and chemokines with mortality. Results: The levels of matrix metalloproteinase 1 (p = 0.003), granulocyte-macrophage colony-stimulating factor (p = 0.040), interleukin 6 (p = 0.047), interleukin 8 (p = 0.050), monocyte chemoattractant protein-1 (p = 0.043), and eotaxin (p = 0.044) were significantly higher in the non-survival group than in the survival group. In the receiver operating characteristic analysis, their areas under the curve were 0.80, 0.68, 0.71, 0.70, 0.70, and 0.72, respectively. Using machine learning with these six cytokines and chemokines, the predictive accuracy for the survival group was 0.94. Conclusions: Our study demonstrated that several cytokines and chemokines in bronchoalveolar lavage fluid could be prognostic predictors in patients with AE-FILD.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease
    Kono, Masato
    Miyashita, Koichi
    Hirama, Ryutaro
    Oshima, Yuiko
    Takeda, Kenichiro
    Mochizuka, Yasutaka
    Tsutsumi, Akari
    Miwa, Hideki
    Miki, Yoshihiro
    Hashimoto, Dai
    Suda, Takafumi
    Nakamura, Hidenori
    RESPIRATORY MEDICINE, 2021, 186
  • [2] Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease
    Kim, Youlim
    Lee, Yeon Joo
    Cho, Young-Jae
    Yoon, Ho Il
    Lee, Jae Ho
    Lee, Choon-Taek
    Park, Jong Sun
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2018, 246 (03): : 147 - 153
  • [3] Value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in acute exacerbation of fibrosing interstitial lung disease: An individualized treatment protocol based on microbiological evidence
    Liu, Dan
    Feng, Jing
    Wan, Nansheng
    Li, Guangsheng
    RESPIROLOGY, 2024, 29 : 15 - 15
  • [4] Value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in acute exacerbation of fibrosing interstitial lung disease: an individualized treatment protocol based on microbiological evidence
    Zhan, Siyu
    Li, Shuo
    Cao, Yaoqian
    Liu, Dan
    Feng, Jing
    BMC PULMONARY MEDICINE, 2024, 24 (01):
  • [5] Bronchoalveolar lavage fluid cytokines in the assessment of interstitial lung disease in systemic sclerosis: a prospective study
    Mittal, Saurabh
    Kumar, Uma
    Guleria, Randeep
    Mohan, Anant
    Madan, Karan
    Bhalla, Ashu Seith
    Mathur, Sandeep
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [6] MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases
    Korthagen, N. M.
    Nagtegaal, M. M.
    van Moorsel, C. H. M.
    Kazemier, K. M.
    van den Bosch, J. M. M.
    Grutters, J. C.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 161 (02): : 342 - 347
  • [7] Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease
    De Santis, Maria
    Bosello, Silvia Laura
    Peluso, Giusy
    Pinnelli, Michela
    Alivernini, Stefano
    Zizzo, Gaetano
    Bocci, Mario
    Capacci, Annunziata
    La Torre, Giuseppe
    Mannocci, Alice
    Pagliari, Gabriella
    Varone, Francesco
    Pistelli, Roberto
    Danza, Francesco Maria
    Ferraccioli, Gianfranco
    CLINICAL RESPIRATORY JOURNAL, 2012, 6 (01): : 9 - 17
  • [9] Acute exacerbation of progressive fibrosing interstitial lung disease: Incidence and outcomes
    Yang, Jiyoul
    Song, Jin Woo
    RESPIROLOGY, 2023, 28 : 59 - 60
  • [10] Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease
    Furuta, Katsuyuki
    Fujimoto, Daichi
    Matsunashi, Atsushi
    Tanaka, Masanori
    Shibaki, Ryota
    Shimada, Yuri
    Nagata, Kazuma
    Tomii, Keisuke
    Yamamoto, Nobuyuki
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58